Donald Bodenner is an Endocrinology/Metabolic physician affiliated with University of Arkansas for Medical Sciences. OpenAlex indexes 89 publications with 4,047 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate
Sponsor: University of Arkansas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
43.8%l-Thyroxine32.3%Levothyroxine Sodium82%Synthroid18%Part D≥86 patientsThyroid Hormone Synthesis Inhibitor10.2%Methimazole100%Part D≥23 patients+ 1 more class in this area
Metabolism & gastrointestinal
32.6%Biguanide (metformin)7.3%Metformin Hcl75%Metformin Hcl Er25%Part D<11 patientsInsulin Analog6.8%Lantus Solostar40%Toujeo Solostar22%Basaglar Kwikpen U-10019%Levemir Flexpen19%Part D<11 patients+ 8 more classes in this area
Cardiovascular
12.9%Statin6.3%Atorvastatin Calcium64%Pravastatin Sodium36%Part D<11 patientsCalcium channel blocker2.6%Amlodipine Besylate100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1997–2006 per NIH RePORTER. The latest:
- STUDY OF METABOLIC AND BIOCHEMICAL CHANGES ASSOCIATED WITH MILD HYPOTHYROIDISM
Univ of Arkansas for Med Scis
FY2006$430M01RR014288 - STUDY OF METABOLIC AND BIOCHEMICAL CHANGES ASSOCIATED WITH MILD HYPOTHYROIDISM
University of Arkansas Med Scis Ltl Rock
FY2005$35,210M01RR014288 - Metabolic and biochemical changes in mild hypothyroidism
University of Arkansas Med Scis Ltl Rock
FY2004$38,776M01RR014288
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Maurizio Zangari, MD
University of Arkansas for Medical Sciences
Jorge Saucedo, MD
University of Arkansas for Medical Sciences
Sharmilan Thanendrarajan, MD
University of Arkansas for Medical Sciences
Purushottam Thapa, MD
University of Arkansas for Medical Sciences
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”